Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI clinical Phase 3 Read more about Medincell: 25% Raise in 2024 UZEDY® Revenue Outlook & Key Milestone Reached for Olanzapine LAI clinical Phase 3
First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma Read more about First patient treated in new phase II clinical trial at Radiumhospitalet in Oslo – promising use of Lytix cancer treatment in patients with early-stage melanoma
beaconsmind Group Expands Healthcare Sector and Gains Renafan as a New Customer Read more about beaconsmind Group Expands Healthcare Sector and Gains Renafan as a New Customer
SpareBank 1 Østlandet: Mandatory notification of trade – Allocation of equity capital certificates to savings programme Read more about SpareBank 1 Østlandet: Mandatory notification of trade – Allocation of equity capital certificates to savings programme
Press Release regarding suspension of trading Read more about Press Release regarding suspension of trading
Reach Subsea ASA - Invitation to presentation of the third quarter results 2024 Read more about Reach Subsea ASA - Invitation to presentation of the third quarter results 2024
NHOA S.A.: Press Release Dated November 6, 2024 Read more about NHOA S.A.: Press Release Dated November 6, 2024
Euronext Oslo Børs - Decision on admission to trading – Paratus Energy Services Ltd. Read more about Euronext Oslo Børs - Decision on admission to trading – Paratus Energy Services Ltd.